Log in

Sun BioPharma Stock Forecast, Price & News

+0.11 (+3.68 %)
(As of 09/28/2020 12:00 AM ET)
Today's Range
Now: $3.10
50-Day Range
MA: $5.12
52-Week Range
Now: $3.10
Volume50,233 shs
Average Volume29,221 shs
Market Capitalization$29.80 million
P/E RatioN/A
Dividend YieldN/A
Sun BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics treatment for unmet medical needs. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer. Its lead product candidate is SBP-101, which is in Phase 1a/1b clinical trial for the treatment of patients with pancreatic cancer. The company has scientific collaborations with pancreatic disease experts Cedars Sinai Medical Center in Los Angeles, the University of Miami; the University of Florida; the Austin Health Cancer Trials Centre in Melbourne, Australia; the Ashford Cancer Centre in Adelaide, Australia; and the Blacktown Cancer and Haematology Centre in Sydney, Australia. Sun BioPharma, Inc. was founded in 2011 and is based in Waconia, Minnesota.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 1.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.36 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolNASDAQ:SNBP



Sales & Book Value

Annual SalesN/A



Market Cap$29.80 million
Next Earnings DateN/A
OptionableNot Optionable
+0.11 (+3.68 %)
(As of 09/28/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SNBP News and Ratings via Email

Sign-up to receive the latest news and ratings for SNBP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Sun BioPharma (NASDAQ:SNBP) Frequently Asked Questions

How has Sun BioPharma's stock price been impacted by Coronavirus (COVID-19)?

Sun BioPharma's stock was trading at $4.81 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SNBP shares have decreased by 35.6% and is now trading at $3.10.
View which stocks have been most impacted by COVID-19

Who are some of Sun BioPharma's key competitors?

What other stocks do shareholders of Sun BioPharma own?

Who are Sun BioPharma's key executives?

Sun BioPharma's management team includes the following people:
  • Dr. Michael T. Cullen Jr., Co-Founder, Exec. Chairman, Pres & CEO (Age 73)
  • Ms. Susan Horvath, VP of Fin., CFO, Sec. & Treasurer (Age 60)
  • Dr. Thomas X. Neenan, Co-Founder & Chief Scientific Officer
  • Ms. Tammy Groene, VP of Operations
  • Dr. Suzanne Gagnon, Chief Medical Officer & Director (Age 62)

What is Sun BioPharma's stock symbol?

Sun BioPharma trades on the NASDAQ under the ticker symbol "SNBP."

When does Sun BioPharma's quiet period expire?

Sun BioPharma's quiet period expires on Wednesday, October 7th. Sun BioPharma had issued 2,545,454 shares in its public offering on August 28th. The total size of the offering was $10,487,270 based on an initial share price of $4.12. During Sun BioPharma's quiet period, insiders and any underwriters that worked on the IPO are restricted from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

How do I buy shares of Sun BioPharma?

Shares of SNBP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Sun BioPharma's stock price today?

One share of SNBP stock can currently be purchased for approximately $3.10.

How big of a company is Sun BioPharma?

Sun BioPharma has a market capitalization of $29.80 million. Sun BioPharma employs 4 workers across the globe.

What is Sun BioPharma's official website?

The official website for Sun BioPharma is www.sunbiopharma.com.

How can I contact Sun BioPharma?

Sun BioPharma's mailing address is 712 VISTA BLVD 305, WACONIA MN, 55387. The company can be reached via phone at 952-479-1196 or via email at [email protected]

This page was last updated on 9/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.